These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36843273)

  • 21. Association of perfluoroalkyl substances exposure in utero with reproductive hormone levels in cord blood in the Hokkaido Study on Environment and Children's Health.
    Itoh S; Araki A; Mitsui T; Miyashita C; Goudarzi H; Sasaki S; Cho K; Nakazawa H; Iwasaki Y; Shinohara N; Nonomura K; Kishi R
    Environ Int; 2016 Sep; 94():51-59. PubMed ID: 27209000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Perfluoroalkyl and Polyfluoroalkyl Substances With Premature Ovarian Insufficiency in Chinese Women.
    Zhang S; Tan R; Pan R; Xiong J; Tian Y; Wu J; Chen L
    J Clin Endocrinol Metab; 2018 Jul; 103(7):2543-2551. PubMed ID: 29986037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternal Plasma Perfluoroalkyl Substances and Miscarriage: A Nested Case-Control Study in the Danish National Birth Cohort.
    Liew Z; Luo J; Nohr EA; Bech BH; Bossi R; Arah OA; Olsen J
    Environ Health Perspect; 2020 Apr; 128(4):47007. PubMed ID: 32319790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediagnostic serum concentrations of per- and polyfluoroalkyl substances and risk of papillary thyroid cancer in the Finnish Maternity Cohort.
    Madrigal JM; Troisi R; Surcel HM; Öhman H; Kivelä J; Kiviranta H; Rantakokko P; Koponen J; Medgyesi DN; Kitahara CM; McGlynn KA; Sampson J; Albert PS; Ward MH; Jones RR
    Int J Cancer; 2024 Mar; 154(6):979-991. PubMed ID: 37902275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perfluorooctanoate and perfluorooctane sulfonate in umbilical cord blood and child cognitive development: Hamamatsu Birth Cohort for Mothers and Children (HBC Study).
    Oh J; Shin HM; Nishimura T; Rahman MS; Takahashi N; Tsuchiya KJ
    Environ Int; 2022 May; 163():107215. PubMed ID: 35378444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perfluorinated chemicals, PFOS and PFOA, enhance the estrogenic effects of 17β-estradiol in T47D human breast cancer cells.
    Sonthithai P; Suriyo T; Thiantanawat A; Watcharasit P; Ruchirawat M; Satayavivad J
    J Appl Toxicol; 2016 Jun; 36(6):790-801. PubMed ID: 26234195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study.
    Ritte R; Lukanova A; Berrino F; Dossus L; Tjønneland A; Olsen A; Overvad TF; Overvad K; Clavel-Chapelon F; Fournier A; Fagherazzi G; Rohrmann S; Teucher B; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Sieri S; Panico S; Tumino R; Vineis P; Quirós JR; Buckland G; Sánchez MJ; Amiano P; Chirlaque MD; Ardanaz E; Sund M; Lenner P; Bueno-de-Mesquita B; van Gils CH; Peeters PH; Krum-Hansen S; Gram IT; Lund E; Khaw KT; Wareham N; Allen NE; Key TJ; Romieu I; Rinaldi S; Siddiq A; Cox D; Riboli E; Kaaks R
    Breast Cancer Res; 2012 May; 14(3):R76. PubMed ID: 22583394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association between total serum isomers of per- and polyfluoroalkyl substances, lipid profiles, and the DNA oxidative/nitrative stress biomarkers in middle-aged Taiwanese adults.
    Lin CY; Lee HL; Hwang YT; Su TC
    Environ Res; 2020 Mar; 182():109064. PubMed ID: 31884197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum Concentrations of Per- and Polyfluoroalkyl Substances and Risk of Renal Cell Carcinoma.
    Shearer JJ; Callahan CL; Calafat AM; Huang WY; Jones RR; Sabbisetti VS; Freedman ND; Sampson JN; Silverman DT; Purdue MP; Hofmann JN
    J Natl Cancer Inst; 2021 May; 113(5):580-587. PubMed ID: 32944748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.
    Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G
    Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic long-term exposure to cadmium air pollution and breast cancer risk in the French E3N cohort.
    Amadou A; Praud D; Coudon T; Danjou AMN; Faure E; Leffondré K; Le Romancer M; Severi G; Salizzoni P; Mancini FR; Fervers B
    Int J Cancer; 2020 Jan; 146(2):341-351. PubMed ID: 30851122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study.
    Suzuki R; Ye W; Rylander-Rudqvist T; Saji S; Colditz GA; Wolk A
    J Natl Cancer Inst; 2005 Nov; 97(21):1601-8. PubMed ID: 16264180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concentrations of Per- and Polyfluoroalkyl Substances in Paired Maternal Plasma and Human Milk in the New Hampshire Birth Cohort.
    Criswell RL; Wang Y; Christensen B; Botelho JC; Calafat AM; Peterson LA; Huset CA; Karagas MR; Romano ME
    Environ Sci Technol; 2023 Jan; 57(1):463-472. PubMed ID: 36574487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of two statistical approaches (Bayesian Kernel Machine Regression and Principal Component Regression) to assess breast cancer risk in association to exposure to mixtures of brominated flame retardants and per- and polyfluorinated alkylated substances in the E3N cohort.
    Frenoy P; Perduca V; Cano-Sancho G; Antignac JP; Severi G; Mancini FR
    Environ Health; 2022 Feb; 21(1):27. PubMed ID: 35216589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex hormone measurements using mass spectrometry and sensitive extraction radioimmunoassay and risk of estrogen receptor negative and positive breast cancer: Case control study in UK Collaborative Cancer Trial of Ovarian Cancer Screening (UKCTOCS).
    Fourkala EO; Blyuss O; Field H; Gunu R; Ryan A; Barth J; Jacobs I; Zaikin A; Dawnay A; Menon U
    Steroids; 2016 Jun; 110():62-69. PubMed ID: 27091764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status.
    Zaineddin AK; Vrieling A; Buck K; Becker S; Linseisen J; Flesch-Janys D; Kaaks R; Chang-Claude J
    Int J Cancer; 2012 Mar; 130(6):1401-10. PubMed ID: 21544804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum perfluoroalkyl substances and breast cancer risk in Japanese women: A case-control study.
    Itoh H; Harada KH; Kasuga Y; Yokoyama S; Onuma H; Nishimura H; Kusama R; Yokoyama K; Zhu J; Harada Sassa M; Tsugane S; Iwasaki M
    Sci Total Environ; 2021 Dec; 800():149316. PubMed ID: 34392213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective study of angiogenic markers and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Falk RT; Staff AC; Bradwin G; Karumanchi SA; Troisi R
    Cancer Causes Control; 2016 Aug; 27(8):1009-17. PubMed ID: 27357932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PFAS and their association with the increased risk of cardiovascular disease in postmenopausal women.
    Arredondo Eve A; Tunc E; Mehta D; Yoo JY; Yilmaz HE; Emren SV; Akçay FA; Madak Erdogan Z
    Toxicol Sci; 2024 Aug; 200(2):312-323. PubMed ID: 38758093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.